Pharmaceutical manufacturers around the world are working to strengthen contamination control in accord with the benchmark set by EU GMP Annex 1, and other regulations, across every stage of sterile production. Download for more details about to build a strong, comprehensive, holistic, and evidence-based Contamination Control Strategy (CCS). Get the latest about: Planning: enterprise-wide expectations and cross-site sharing of best practices between teams People: education and support for individuals and teams who collectively contribute Products: must adhere to the highest quality standards if associated risks are to be minimized
